There have been 50 recent insider transactions recorded for Xenon Pharmaceuticals Inc. (XENE), including 28 buys and 20 sells. Total insider buying was valued at $23.98M and total insider selling at $4.33M.
Notable insiders with recent activity include Mortimer Ian, Difabio Andrea, Kenney Christopher John. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — XENE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-13 |
Mortimer Ian |
President & CEO |
Informative Sell |
7,308 |
$55.23 |
$403.58K |
19,923 |
| 2026-03-13 |
Difabio Andrea |
Chief Legal Officer |
Informative Sell |
1,342 |
$55.23 |
$74.11K |
7,301 |
| 2026-03-13 |
Kenney Christopher John |
Chief Medical Officer |
Informative Sell |
1,410 |
$55.23 |
$77.87K |
7,069 |
| 2026-03-12 |
Mortimer Ian |
President & CEO |
Option Exercise |
12,500 |
- |
- |
27,231 |
| 2026-03-12 |
Difabio Andrea |
Chief Legal Officer |
Option Exercise |
3,750 |
- |
- |
8,643 |
| 2026-03-12 |
Kenney Christopher John |
Chief Medical Officer |
Option Exercise |
3,750 |
- |
- |
8,479 |
| 2026-03-10 |
Mortimer Ian |
President & CEO |
Informative Sell |
11,269 |
$60.11 |
$677.36K |
14,731 |
| 2026-03-10 |
Difabio Andrea |
Chief Legal Officer |
Informative Sell |
2,607 |
$60.11 |
$156.7K |
4,893 |
| 2026-03-10 |
Kenney Christopher John |
Chief Medical Officer |
Informative Sell |
2,771 |
$60.11 |
$166.56K |
4,729 |
| 2026-03-09 |
Mortimer Ian |
President & CEO |
Option Exercise (Sell) |
20,000 |
- |
- |
- |
| 2026-03-09 |
Difabio Andrea |
Chief Legal Officer |
Option Exercise (Sell) |
7,500 |
- |
- |
- |
| 2026-03-09 |
Kenney Christopher John |
Chief Medical Officer |
Option Exercise (Sell) |
7,500 |
- |
- |
- |
| 2026-01-09 |
Mortimer Ian |
President & CEO |
RSU Award |
65,000 |
- |
- |
65,000 |
| 2026-01-09 |
Cline Darren S |
Chief Commercial Officer |
RSU Award |
20,000 |
- |
- |
20,000 |
| 2026-01-09 |
Difabio Andrea |
Chief Legal Officer |
RSU Award |
15,000 |
- |
- |
15,000 |
| 2026-01-09 |
Kenney Christopher John |
Chief Medical Officer |
RSU Award |
20,000 |
- |
- |
20,000 |
| 2026-01-02 |
Mortimer Ian |
President & CEO |
Option Exercise (Sell) |
40,000 |
$7.49 |
$299.6K |
- |
| 2025-12-08 |
Mortimer Ian |
President & CEO |
Informative Sell |
2,010 |
$46.32 |
$93.1K |
6,000 |
| 2025-12-05 |
Mortimer Ian |
President & CEO |
Informative Sell |
14,375 |
$45.03 |
$647.31K |
16,830 |
| 2025-11-28 |
Mortimer Ian |
President & CEO |
Informative Sell |
97 |
$45.01 |
$4.37K |
31,205 |
| 2025-10-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
Unknown |
- |
- |
- |
- |
| 2025-10-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2025-10-01 |
Mortimer Ian |
President, CEO & Interim CFO |
Option Exercise (Sell) |
25,000 |
$7.69 |
$192.25K |
- |
| 2025-06-23 |
Cline Darren S |
Chief Commercial Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-23 |
Cline Darren S |
Chief Commercial Officer |
RSU Award |
185,800 |
$31.49 |
$5.85M |
185,800 |
| 2025-06-05 |
Patou Gary |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Machado Patrick |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Svoronos Dawn |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Gannon Steven |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Gover Justin D. |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Garofalo Elizabeth A. |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-06-05 |
Cannon Gillian |
Director |
RSU Award |
2,645 |
- |
- |
2,645 |
| 2025-05-14 |
Gannon Steven |
Director |
Option Exercise (Sell) |
5,144 |
$12.57 |
$64.66K |
- |
| 2025-03-12 |
Mortimer Ian |
President & CEO |
RSU Award |
50,000 |
- |
- |
50,000 |
| 2025-03-12 |
Difabio Andrea |
Chief Legal Officer |
RSU Award |
15,000 |
- |
- |
15,000 |
| 2025-03-12 |
Kenney Christopher John |
Chief Medical Officer |
RSU Award |
15,000 |
- |
- |
15,000 |
| 2025-01-27 |
Mortimer Ian |
President & CEO |
Option Exercise (Sell) |
16,315 |
$17.76 |
$289.75K |
- |
| 2025-01-24 |
Mortimer Ian |
President & CEO |
Option Exercise (Sell) |
22,468 |
$17.76 |
$399.03K |
16,315 |
| 2025-01-23 |
Mortimer Ian |
President & CEO |
Informative Sell |
16,217 |
$40.08 |
$649.98K |
31,302 |
| 2024-12-18 |
Aulin Sherry |
Chief Financial Officer |
Option Exercise (Sell) |
9,334 |
$9.44 |
$88.11K |
- |
| 2024-11-22 |
Patou Gary |
Director |
Option Exercise (Sell) |
3,086 |
$13.48 |
$41.6K |
- |
| 2024-06-05 |
Patou Gary |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Machado Patrick |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Svoronos Dawn |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Gannon Steven |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Gover Justin D. |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Garofalo Elizabeth A. |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-06-05 |
Cannon Gillian |
Director |
RSU Award |
15,542 |
$38.16 |
$593.08K |
15,542 |
| 2024-03-11 |
Mortimer Ian |
President & CEO |
RSU Award |
250,000 |
$44.37 |
$11.09M |
250,000 |
| 2024-03-11 |
Robin Sherrington |
EVP, Strategy & Innovation |
RSU Award |
65,000 |
$44.37 |
$2.88M |
65,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
